About ALZARROK BIO LLC
ALZARROK is focused on developing a peptide drug, ALZ100, designed for intranasal delivery to halt cognitive decline in Alzheimer’s disease. The drug aims to inhibit neuroinflammation and neurodegeneration through a multi-targeted approach.
Development of peptide drugsIntranasal drug delivery system designPatent-pending therapeutic technology
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ALZARROK BIO LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.